肌萎缩侧索硬化预后相关的血液学标志物

doi:10.6040/j.issn.1671-7554.0.2015.1158

摘要/Abstract

摘要： 目的探讨部分血液指标与肌萎缩侧索硬化(ALS)患者预后的关系,寻找预测ALS患者预后的血液学标志物。方法回顾性分析2007年1月至2012年12月山东大学齐鲁医院收治的116例ALS患者的临床资料和血常规检查结果,采用Kaplan-Meier生存分析计算中位生存时间,Log-rank分析各单因素变量与生存时间的关系,Cox风险比例模型分析多变量对生存时间的影响。结果生存曲线分析显示,具有较高水平白蛋白、肌酐(sCr)、甘油三酯(TG)、低密度脂蛋白/高密度脂蛋白(LDL/HDL)、尿酸(UA)的患者生存时间较长,其中sCr、TG水平与ALS患者生存期呈显著的剂量依赖效应(P<0.05)。多因素分析显示,sCr是影响ALS患者预后的独立因素。结论血脂水平和营养状态与ALS患者预后密切相关,sCr可作为预测ALS患者预后的血液学标志物。

关键词: 肌萎缩侧索硬化, 血液指标, 预后, 血脂, 血清肌酐

Abstract: Objective To investigate the relationship between some of hematological factors and the prognosis of amyotrophic lateral sclerosis(ALS), and search for hematology markers which could predict the prognosis of patients with ALS. Methods The retrospective study included 116 patients with ALS from the Qilu Hospital of Shandong University during January 2007 to December 2012. Their clinical data and routine hematological parameters were collected. Survival of patients was calculated by using the Kaplan-Meier method. The relationship between levels of hematological parameters and the survival curve of patients were analyzed by Log-rank test. Multivariate effect on survival time was analyzed with Cox proportional hazard model. Results The survival increased in patients with higher levels of serum albumin, creatinine(sCr), triglyceride(TG), lowdensity lipoprotein/ high density lipoprotein(LDL/HDL)or uric acid(UA). Moreover, a dose-response effect was found only in sCr and TG(P<0.05). Multivariable analysis showed that only sCr was an independent hematological marker affecting the prognosis of patients with ALS. Conclusion Blood lipid level and nutritional status are associated with survival of ALS patients, and sCr can be used as a potential independent prognostic biomarker of ALS.

Key words: Amyotrophic lateral sclerosis, Hematological parameter, Serum creatinine, Prognosis

中图分类号:

R741

马琳,张冬,唐蕾,叶嗣源,焉传祝,曹丽丽. 肌萎缩侧索硬化预后相关的血液学标志物[J]. 山东大学学报（医学版）, 2016, 54(4): 46-50.

MA Lin, ZHANG Dong, TANG Lei, YE Siyuan, YAN Chuanzhu, CAO Lili. Prognostic hematological biomarkers of amyotrophic lateral sclerosis[J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2016, 54(4): 46-50.

参考文献

[1] Chio A, Logroscino G, Hardiman O, et al. Prognostic factors in ALS: a critical review[J]. Amyotroph Lateral Scler, 2009, 10(5-6): 310-323.
[2] Chiò A, Calvo A, Bovio G, et al. Amyotrophic lateral sclerosis outcome measures and the role of albumin and creatinine: a population-based study[J]. JAMA Neurol, 2014, 71(9): 1134-1142.
[3] Dorst J, Kuhnlein P, Hendrich C, et al. Patients with elevated triglyceride and cholesterol serum levels have a prolonged survival in amyotrophic lateral sclerosis[J]. J Neurol, 2011, 258(4): 613-617.
[4] Ikeda K, Hirayama T, Takazawa T, et al. Relationships between disease progression and serum levels of lipid, urate, creatinine and ferritin in Japanese patients with amyotrophic lateral sclerosis: a cross-sectional study[J]. Intern Med, 2012, 51(12): 1501-1508.
[5] Zoccolella S, Simone IL, Capozzo R, et al. An exploratory study of serum urate levels in patients with amyotrophic lateral sclerosis[J]. J Neurol, 2011, 258(2):238-243.
[6] Brooks BR, Miller RG, Swash M, et al. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis[J]. Amyotroph Lateral Scler Other Motor Neuron Disord, 2000, 1(5): 293-299.
[7] Korner S, Hendricks M, Kollewe K, et al. Weight loss, dysphagia and supplement intake in patients with amyotrophic lateral sclerosis(ALS): impact on quality of life and therapeutic options[J]. BMC Neurol, 2013, 13:84. doi: 10.1186/1471-2377-13-84.
[8] Kerentz AJ, Williams AC, Nattrass M. Abnomal regulation of carbohydrate metabolism in motor neurone disease[J]. Diabetes Res, 1991, 16(2): 93-99.
[9] Dupuis L, Oudart H, René F, et al. Evidence for defective energy homeostasis in amyotrophic lateral sclerosis: benefit of a high-energy diet in a transgenic mouse model[J]. Proc Natl Acad Sci U S A, 2004, 101(30): 11159-11164.
[10] Thau N, Knippenberg S, Korner S, et al. Decreased mRNA expression of PGC-1alpha and PGC-1alpha-regulated factors in the SOD1G93A ALS mouse model and in human sporadic ALS[J]. J Neuropathol Exp Neurol, 2012, 71(12): 1064-1074.
[11] Barroso E, Rodriguez-Calvo R, Serrano-Marco L, et al. The PPARbeta/delta activator GW501516 prevents the down-regulation of AMPK caused by a high-fat diet in liver and amplifies the PGC-1alpha-Lipin 1-PPARalpha pathway leading to increased fatty acid oxidation[J]. Endocrinology, 2011, 152(5): 1848-1859.
[12] Paganoni S, Deng J, Jaffa M, et al. Body mass index, not dyslipidemia, is an independent predictor of survival in amyotrophic lateral sclerosis[J]. Muscle Nerve, 2011, 44(1): 20-24.
[13] Jawaid A, Murthy SB, Wilson AM, et al. A decrease in body mass index is associated with faster progression of motor symptoms and shorter survival in ALS[J]. Amyotroph Lateral Scler, 2010, 11(6): 542-548.
[14] Reich-Slotky R, Andrews J, Cheng B, et al. Body mass index(BMI)as predictor of ALSFRS-R score decline in ALS patients[J]. Amyotroph Lateral Scler Frontotemporal Degener, 2013, 14(3): 212-216.
[15] Edwards IR, Star K, Kiuru A. Statins, neuromuscular degenerative disease and an amyotrophic lateral sclerosis-like syndrome: an analysis of individual case safety reports from vigibase[J]. Drug Saf, 2007, 30(6): 515-525.
[16] Wyss M, Kaddurah-Daouk R. Creatine and creatinine metabolism[J]. Physiol Rev, 2000, 80(3): 1107-1213.
[17] Hashizume A, Katsuno M, Banno H, et al. Longitudinal changes of outcome measures in spinal and bulbar muscular atrophy[J]. Brain, 2012, 135(pt 9): 2838-2848.
[18] Reynolds A, Laurie C, Lee Mosley R, et al. Oxidative stress and the pathogenesis of neurodegenerative disorders[J]. Intern Rev Neurobiol, 2007, 82: 297-325.
[19] Du Y, Chen CP, Tseng CY, et al. Astroglia-mediated effects of uric acid to protect spinal cord neurons from glutamate toxicity[J]. Glia, 2007, 55(5): 463-472.
[20] Weisskopf MG, OReilly E, Chen H, et al. Plasma urate and risk of Parkinsons disease[J]. Am J Epidemiol, 2007, 166(5): 561-567.
[21] Ruggiero C, Cherubini A, Lauretani F, et al. Uric acid and dementia in community-dwelling older persons[J]. Dement Geriatr Cogn Disord, 2009, 27(4): 382-389.
[22] Keizman D, Ish-Shalom M, Berliner S, et al. Low uric acid levels in serum of patients with ALS: further evidence for oxidative stress?[J]. J Neurol Sci, 2009, 285(1-2): 95-99.

相关文章 15

[1]	栗英林,宋道庆,徐忠华. 应用生物信息学方法分析肾透明细胞癌中FKBP11的表达[J]. 山东大学学报 (医学版), 2020, 1(9): 45-51.
[2]	付洁琦,张曼,张晓璐,李卉,陈红. Toll样受体4抑制过氧化物酶体增殖物激活受体γ加重血脂蓄积的分子机制[J]. 山东大学学报 (医学版), 2020, 1(7): 24-31.
[3]	史爽,李娟,米琦,王允山,杜鲁涛,王传新. 胃癌miRNAs预后风险评分模型的构建与应用[J]. 山东大学学报 (医学版), 2020, 1(7): 47-52.
[4]	路璐,孙志钢,张楠. 继发性嗜血细胞综合征1例[J]. 山东大学学报 (医学版), 2020, 1(7): 122-124.
[5]	李星凯,刘战业,姜运峰,李军. 原发性中央型和周围型肺鳞癌临床病理学及预后差异[J]. 山东大学学报（医学版）, 2017, 55(9): 73-78.
[6]	宗帅,肖东杰,刘华,郏雁飞,马晓丽,李焕杰,黎娉,郑燕,汪运山. CSN5在胃癌中的表达及与患者预后的相关性[J]. 山东大学学报（医学版）, 2017, 55(7): 12-16.
[7]	王美建,侯新国,梁凯,陈丽. 山东省城市中老年人群血脂现状调查[J]. 山东大学学报（医学版）, 2017, 55(5): 70-75.
[8]	孙启晶,陈方方,李春晓,张才擎. PNI及HGB评估中晚期非小细胞肺癌患者预后的临床价值[J]. 山东大学学报（医学版）, 2017, 55(4): 55-59.
[9]	董尧,宋亚林,田涛,高建国. 确诊8年未经治疗却无明显进展的阴茎恶性黑色素瘤1例报道[J]. 山东大学学报（医学版）, 2017, 55(3): 125-126.
[10]	林家香,郭子嘉,苏鹏,王晓,郭雅欣,吴晓娟,相磊,周志强, 王妍,崔秀杰,潘爱凤,郭成浩. 致癌蛋白CIP2A在乳腺导管上皮恶变中的作用及预测浸润性导管癌患者预后的能力[J]. 山东大学学报（医学版）, 2017, 55(3): 100-106.
[11]	周兰兰,潘学谊,郭煜. 48例急性混合细胞表型白血病患者的临床特征及预后[J]. 山东大学学报（医学版）, 2017, 55(2): 79-83.
[12]	张希英,翟春颜,李劲松,韩博. 中国尤文肉瘤患者EZH2蛋白表达与临床病理学参数及预后的关系[J]. 山东大学学报（医学版）, 2017, 55(2): 84-91.
[13]	刘惠苓,王兴文,冯少滨,冯虹,韩俊庆. B类I型清道夫受体的高表达与结肠癌患者预后的相关性[J]. 山东大学学报（医学版）, 2017, 55(10): 84-89.
[14]	张琳,李敬,王泽,张江涛,马增香,石玉华. 多囊卵巢综合征患者促甲状腺激素对血糖、血脂的影响[J]. 山东大学学报（医学版）, 2017, 55(1): 80-84.
[15]	李晓宁,崔连群. 急性心肌梗死合并多支血管病变患者非梗死相关动脉处理的时机[J]. 山东大学学报（医学版）, 2016, 54(8): 50-54.

多维度评价

Viewed

Full text

Abstract

Cited

Shared

Discussed